350542 <common-name>2-[4-[(e)-[3-[(2-ethylanilino)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]phenoxy]-n-[(e)-1-(4-methoxyphenyl)ethylideneamino]acetamide</common-name> <description>2-[4-[(e)-[3-[(2-ethylanilino)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]phenoxy]-n-[(e)-1-(4-methoxyphenyl)ethylideneamino]acetamide has the chemical formula C30H30N4O4S2. With an average molecular weight of 574.70 g/mol, 2-[4-[(e)-[3-[(2-ethylanilino)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]phenoxy]-n-[(e)-1-(4-methoxyphenyl)ethylideneamino]acetamide is a heavy molecule.</description> <cas>139207-49-1</cas> <pubchem-id>9588724</pubchem-id> <chemical-formula>C30H30N4O4S2</chemical-formula> <weight>574.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:40:29Z</created-at> <updated-at type="dateTime">2026-08-31T15:40:29Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCC1=CC=CC=C1NCN2C(=O)C(=CC3=CC=C(C=C3)OCC(=O)NN=C(C)C4=CC=C(C=C4)OC)SC2=S</moldb-smiles> <moldb-formula>C30H30N4O4S2</moldb-formula> <moldb-inchi>InChI=1S/C30H30N4O4S2/c1-4-22-7-5-6-8-26(22)31-19-34-29(36)27(40-30(34)39)17-21-9-13-25(14-10-21)38-18-28(35)33-32-20(2)23-11-15-24(37-3)16-12-23/h5-17,31H,4,18-19H2,1-3H3,(H,33,35)/b27-17+,32-20+</moldb-inchi> <moldb-inchikey>LAIOYWKCYNPYIB-PMMFSTIFSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">574.1708478</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.7</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346435</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[4-[(e)-[3-[(2-ethylanilino)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]phenoxy]-n-[(e)-1-(4-methoxyphenyl)ethylideneamino]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Benzenoids</superklass> <klass>Phenol ethers</klass> <subklass>Anisoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300847</sync-id> <structure-inchikey>LAIOYWKCYNPYIB-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>400040000000008000420000000000000000000000800001000000000000004040820000222000000000000000000000000000000000000000000000000000000000000000000800000000000000200000100003080002040000080000000400000100000100400001000100000000000001081000000000000400004010000000400000008000000000000080800000000001000000c000010000000000000000000000001400000008400000008000002008000000000000040000008000000000000004000000000040000000000000c000040000000210000400000100000000000000000040010000800400000000000000008000080000004008</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAoAAAAKwAAAIABBgBgAAAAAQMGAGAAAAAC AgZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMB BkAoAAAAAwQHAGgAAAADAgEGAGAAAAACAgcAKAAAAAMDBgAoAAAAAwQIACgA AAADAgYAKAAAAAMEBgBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAAD AwEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQgAKAAAAAMCBgBgAAAAAgIG ACgAAAADBAgAKAAAAAMCBwBoAAAAAwIBBwAoAAAAAwMGACgAAAADBAYAYAAA AAEDBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMD AQZAaAAAAAMDAQgAKAAAAAMCBgBgAAAAAQMQACAAAAACBgAoAAAAAwQQACgA AAADAgsAAQABAgACA2gMAwRoDAQFaAwFBmgMBgdoDAcIIAgJAAkKAAoLIAsM KAILDSANDigCDg8gDxBoDBARaAwREmgMEhNoDBMUaAwSFSAVFgAWFwAXGCgC FxkgGRogGhsoAhscABsdIB0eaAweH2gMHyBoDCAhaAwhImgMICMgIyQADSUA JSYAJicoAgcCaAwmCiAUD2gMIh1oDEIEAAAABgIHBgUEAwULCiYlDQYQERIT FA8GHh8gISIdFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:32Z</structure-indexed-at> </compound>